First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 2.5% of the 265,711 shares held after it.
No other insider sold within 30 days.
217 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MacNevin William K. sold about $48.1K of SSRM on Jan 3, 2025, the largest insider sale at the company since 2023; 217 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 15.3% of the 52,306 shares held after it.
No other insider bought within 30 days.
217 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Anglin Arthur Michael bought about $129.8K of SSRM on May 12, 2023, the largest insider purchase at the company on our record; 217 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Mar 8, 2023.
The trade is 7.4% of the 61,683 shares held after it.
4 other insiders sold within 30 days.
217 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer White Alison Lynn sold about $70.8K of SSRM on Apr 3, 2023; 4 other insiders sold within 30 days and 217 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jan 4, 2023.
The trade is 2.4% of the 34,282 shares held after it.
4 other insiders sold within 30 days.
217 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Ebbett John sold about $10.9K of SSRM on Mar 8, 2023; 4 other insiders sold within 30 days and 217 funds added in the latest 13F quarter.
29 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SSRM planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
SSRM mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
MIDAS DISCOVERY
$2.7M position · as of 2026-06-30
8.0%
Amplify Junior Silver Miners ETF
$164.7M position · as of 2026-06-30
4.8%
Global X Silver Miners ETF
$152.1M position · as of 2026-07-31
3.9%
Global X Gold Explorers ETF
$3.4M position · as of 2026-07-31
3.3%
Sprott Gold Miners ETF
$16.3M position · as of 2026-06-30
2.9%
Global X MSCI Argentina ETF
$22.4M position · as of 2026-07-31
2.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Rod Antal
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$7.6M
$23.8M
$3.0M
+14%
+161%
2024
$5.1M
$2.5M
$1.9M
-64%
-6%
2023
$5.3M
-$149.1K
$2.0M
-44%
-22%
2022
$4.6M
$787.9K
$2.4M
-20%
-31%
2021
$5.6M
$1.4M
$1.9M
-11%
-21%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 217 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM SSRM
FY Dec 2025
$1.6B
FY Dec 2024
$995.6M
FY Dec 2023
$1.4B
FY Dec 2022
$1.1B
FY Dec 2021
$1.5B
Jun 2026
$443.8M
Mar 2026
$581.8M
Dec 2025
$521.7M
Sep 2025
$385.8M
Jun 2025
$405.5M
Mar 2025
$316.6M
Dec 2024
$323.2M
Sep 2024
$257.4M
At each fiscal year end
Single quarter
Net margin, TTM
+12.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM SSRM
FY Dec 2025
+24.3%
FY Dec 2024
-26.2%
FY Dec 2023
-6.9%
FY Dec 2022
+16.9%
FY Dec 2021
+25.0%
Jun 2026
+21.9%
Mar 2026
-18.3%
Dec 2025
+34.8%
Sep 2025
+17.0%
Jun 2025
+22.2%
Mar 2025
+18.6%
Dec 2024
+1.7%
Sep 2024
+4.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$352.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM SSRM
FY Dec 2025
$241.1M
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
$67.8M
Mar 2026
$175.7M
Dec 2025
$106.4M
Sep 2025
$2.2M
Jun 2025
$95.1M
Mar 2025
$37.5M
Dec 2024
$56.4M
Sep 2024
-$33.1M
At each fiscal year end
Single quarter
Debt to equity
0.02x
long-term 2026-03-31 plus current 2026-06-30; equity 2026-06-30
Debt to equity SSRM
FY Dec 2025
0.08x
FY Dec 2024
0.07x
FY Dec 2023
0.07x
FY Dec 2022
0.08x
FY Dec 2021
0.10x
Jun 2026
0.02x
Mar 2026
0.02x
Dec 2025
0.08x
Sep 2025
0.07x
Jun 2025
0.07x
Mar 2025
0.07x
Dec 2024
0.07x
Sep 2024
0.07x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
9.03x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-06-30
Cash flow to debt SSRM
FY Dec 2025
1.68x
FY Dec 2024
0.18x
FY Dec 2023
1.85x
FY Dec 2022
0.54x
FY Dec 2021
1.66x
Jun 2026
9.03x
Mar 2026
9.89x
Dec 2025
1.68x
Sep 2025
1.73x
Jun 2025
1.46x
Mar 2025
0.43x
Dec 2024
0.18x
Sep 2024
0.65x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SSRM
FY Dec 2025
+12.0%
FY Dec 2024
-8.1%
FY Dec 2023
-2.8%
FY Dec 2022
+5.5%
FY Dec 2021
+10.7%
Jun 2026
+7.1%
Mar 2026
+6.8%
Dec 2025
+12.0%
Sep 2025
+6.8%
Jun 2025
+5.2%
Mar 2025
+2.7%
Dec 2024
-8.1%
Sep 2024
-14.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SSRM
FY Dec 2025
+7.0%
FY Dec 2024
-4.9%
FY Dec 2023
-1.8%
FY Dec 2022
+3.7%
FY Dec 2021
+7.1%
Jun 2026
+4.7%
Mar 2026
+4.0%
Dec 2025
+7.0%
Sep 2025
+4.0%
Jun 2025
+3.0%
Mar 2025
+1.6%
Dec 2024
-4.9%
Sep 2024
-8.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital SSRM
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
+5.5%
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+9.3%
Jun 2025
+7.6%
Mar 2025
+3.1%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed SSRM
FY Dec 2025
n/a
FY Dec 2024
-6.3%
FY Dec 2023
-2.6%
FY Dec 2022
+3.8%
FY Dec 2021
+9.0%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+7.6%
Jun 2025
+6.2%
Mar 2025
+3.1%
Dec 2024
-6.3%
Sep 2024
-12.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
25.57x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing SSRM
FY Dec 2025
11.78x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
17.61x
FY Dec 2021
10.79x
Jun 2026
25.48x
Mar 2026
27.74x
Dec 2025
11.78x
Sep 2025
23.48x
Jun 2025
16.33x
Mar 2025
24.46x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$4.1B
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term 2026-03-31 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value SSRM
FY Dec 2025
$4.2B
FY Dec 2024
$1.2B
FY Dec 2023
$1.9B
FY Dec 2022
$2.9B
FY Dec 2021
$3.2B
Jun 2026
$4.2B
Mar 2026
$5.4B
Dec 2025
$4.2B
Sep 2025
$4.8B
Jun 2025
$2.4B
Mar 2025
$1.9B
Dec 2024
$1.2B
Sep 2024
$1.0B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.1%
TTM free cash flow over market value at close 2026-10-23
FCF yield SSRM
FY Dec 2025
+5.4%
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+6.0%
Mar 2026
+6.3%
Dec 2025
+5.4%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.60x
P/E over trailing EPS growth of 42%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing SSRM
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.60x
Mar 2026
0.17x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SSRM ranks highest on financial health (89th percentile) and growth (89th), and lowest on risk and compliance (38th), among Investment Vehicles peers.
Profitability
72
Inputs
Return on equity+7.1% · 56 pct, universe of 3,863
Return on assets+4.7% · 88 pct, sector of 167
Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
89
Inputs
Debt to equity0.02x · 83 pct, universe of 3,589
Cash flow to debt9.03x · 96 pct, universe of 3,315
Growth
89
Inputs
Revenue growth, YoY+62.4% · 89 pct, universe of 4,656
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
72
Inputs
Funds adding, latest quarter217 · 99 pct, sector of 254
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$280K · 44 pct, universe of 1,063
Risk and compliance
38
Inputs
Short interest, % of float+4.0% · 3 pct, sector of 293
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+6.9% · 74 pct, universe of 3,661
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.